Mark Coleman

Director, Axsome Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$8.2M

Companies

Latest trade

Jun 10, 2026

Companies

Axsome Therapeutics, Inc.Director −$8.2M

Trades

AXSM Sold 643 shares at $249.00 · planned $0.2M Jun 10

AXSM Sold 5,537 shares at $223.39 · planned $1.2M Jun 2

AXSM Sold 6,000 shares at $230.30 · planned $1.4M Jun 1

AXSM Sold 6,000 shares at $233.46 · planned $1.4M May 29

AXSM Sold 25,000 shares at $161.11 · planned $4.0M Feb 26

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.